ReviewCancer biomarkers : section A of Disease markers2024

EMP3: A promising biomarker for tumor prognosis and targeted cancer therapy.

Wenjing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.